Yale Cancer Center study reveals new pathway for brain tumor therapy

(Yale University) In a new study led by Yale Cancer Center, researchers show the nucleoside transporter ENT2 may offer an unexpected path to circumventing the blood-brain barrier (BBB) and enabling targeted treatment of brain tumors with a cell-penetrating anti-DNA autoantibody. The study was published today online in the Journal of Clinical Investigation Insight.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news